Journal Of Pharmacology And Experimental Therapeutics

Journal Of Pharmacology And Experimental Therapeutics

药理学与实验治疗学杂志

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Journal Of Pharmacology And Experimental Therapeutics》是由American Society for Pharmacology and Experimental Therapeutics出版社于1909年创办的英文国际期刊(ISSN: 0022-3565,E-ISSN: 1521-0103),该期刊长期致力于药学领域的创新研究,主要研究方向为医学-药学。作为SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA未开放获取模式(OA占比0.1544...%),以发表药学领域等方向的原创性研究为核心(研究类文章占比84.30%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在121篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Journal Of Pharmacology And Experimental Therapeutics审稿周期约为 约1.0个月 。该刊近年未被列入国际预警名单,年发文量约121篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 121 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 126 / 354

64.5%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 81 / 354

77.26%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:6.9 SJR:0.829 SNIP:0.736
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology Q2 92 / 313

70%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Molecular Medicine Q2 67 / 178

62%

期刊发文

  • The Functions and Mechanisms of Translatable Circular RNAs

    Author: Liu, Chang; Wu, Xinying; Gokulnath, Priyanka; Li, Guoping; Xiao, Junjie

    Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2023; Vol. 384, Issue 1, pp. 52-60. DOI: 10.1124/jpet.122.001085

  • CircRNA_33702 Promotes Renal Fibrosis by Targeting the miR-29b-3p/WNT1-Inducible Signaling Pathway Protein 1 Pathway

    Author: Ai, Kai; Yi, Lei; Wang, Yinhuai; Li, Yuan

    Journal: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2023; Vol. 384, Issue 1, pp. 61-71. DOI: 10.1124/jpet.122.001280

  • A Comparison of the Central versus Peripheral Gastrointestinal Prokinetic Activity of Two Novel Ghrelin Mimetics.

    Author: Mohammadi EN1, Pietra C1, Giuliano C1, Fugang L1, Greenwood-Van Meerveld B2.

    Journal: J Pharmacol Exp Ther. 2019 Jan;368(1):116-124. doi: 10.1124/jpet.118.250738. Epub 2018 Oct 30.

  • Methyleugenol Potentiates Central Amygdala GABAergic Inhibition and Reduces Anxiety.

    Author: Liu YM1, Fan HR1, Deng S1, Zhu T1, Yan Y1, Ge WH1, Li WG2, Li F2.

    Journal: J Pharmacol Exp Ther. 2019 Jan;368(1):1-10. doi: 10.1124/jpet.118.250779. Epub 2018 Nov 2.

  • Exploring the Potential of RET Kinase Inhibition for Irritable Bowel Syndrome: A Preclinical Investigation in Rodent Models of Colonic Hypersensitivity.

    Author: Russell JP1, Mohammadi E1, Ligon CO1, Johnson AC1, Gershon MD1, Rao M1, Shen Y1, Chan CC1, Eidam HS1, DeMartino MP1, Cheung M1, Oliff AI1, Kumar S1, Greenwood-Van Meerveld B2.

    Journal: J Pharmacol Exp Ther. 2019 Feb;368(2):299-307. doi: 10.1124/jpet.118.252973. Epub 2018 Nov 9.

  • Inhibitory Effects of Mas-Related Gene C Receptor on Chronic Morphine-Induced Spinal Glial Activation in Rats.

    Author: Zhang Y1, Wang M1, Lu Q1, Li Q1, Lin M1, Huang J1, Hong Y2.

    Journal: J Pharmacol Exp Ther. 2019 Feb;368(2):237-245. doi: 10.1124/jpet.118.252494. Epub 2018 Nov 28.

  • Inhibition of COX-2 and EGFR by Melafolone Improves Anti-PD-1 Therapy through Vascular Normalization and PD-L1 Downregulation in Lung Cancer.

    Author: Tang H1, Liu Y1, Wang C1, Zheng H1, Chen Y1, Liu W1, Chen X1, Zhang J1, Chen H1, Yang Y1, Yang J2.

    Journal: J Pharmacol Exp Ther. 2019 Mar;368(3):401-413. doi: 10.1124/jpet.118.254359. Epub 2018 Dec 27.